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Edited by Beat ImhofAbstract The adapter 3BP2 is involved in leukocyte signaling
downstream Src/Syk-kinases coupled immunoreceptors. Here,
we show that 3BP2 directly interacts with the endocytic scaﬀold
protein CIN85 and the actin-binding protein HIP-55. 3BP2 co-
localized with CIN85 and HIP-55 in T cell rafts and at the T
cell/APC synapse, an active zone of receptors and proteins recy-
cling. A binding region of CIN85 SH3 domains on 3BP2 was
mapped to a PVPTPR motif in the ﬁrst proline-rich region of
3BP2, whereas the C-terminal SH3 domain of HIP-55 bound
a more distal proline-rich domain of 3BP2. Together, our data
suggest an unexpected role of 3BP2 in endocytic and cytoskele-
tal regulation through its interaction with CIN85 and HIP-55.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: 3BP2; CIN85; HIP-55; Src homology 3 domain;
Proline-rich domain1. Introduction
Adapter proteins are key components of signal transduction
pathways of T and B lymphocyte antigen receptors coupled to
protein tyrosine kinases (PTKs) by regulating the assembly of
large molecular complexes [1,2]. They act through protein–pro-
tein or protein–lipid interactions [3]. Molecular scaﬀolds com-
posed of adapter proteins and enzymes, such as phospholipase
C-c(PLC-c), phosphatidylinositol 3-kinase and Vav guanine
nucleotide exchange factors, are assembled and activated at
the plasma membrane by Src and/or Syk PTKs. These scaﬀolds
transduce signals to the cytoplasm, cytoskeleton and nucleus to
activate gene expression and metabolic changes involved in
lymphocyte proliferation, diﬀerentiation and motility.
In a screen for Syk kinases interacting proteins in lympho-
cyte, we identiﬁed Abl SH3 binding protein 2 (3BP2) [4], aAbbreviations: 3BP2, Abl SH3 binding protein 2; CIN85, Cbl inter-
acting protein of 85 kDa; CMS, Cas ligand with multiple SH3 dom-
ains; HIP-55, hematopoietic progenitor kinase 1 interacting protein of
55 kDa; SH, src homology; PR, proline-rich; ADF-H, actin-depoly-
merizing factor homology; PTK, protein tyrosine kinase; TCR, T cell
receptor; BCR, B cell receptor; APC, antigen-presenting cell; GEMs,
glycosphigolipid-enriched membrane microdomains; GST, glutathione
S-transferase; GFP, green ﬂuorescent protein; SE, staphylococcal
enterotoxin
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doi:10.1016/j.febslet.2007.01.084cytoplasmic adapter originally identiﬁed as a protein interact-
ing with the SH3 domain of Abl [5]. 3BP2 (also known as
SH3BP2) is preferentially expressed in hematopoietic tissues
[4,6] and regulates transcriptional activities through calcineu-
rin and Ras dependent pathways in T lymphocytes [4]. A posi-
tive regulatory role of 3BP2 in B cell receptor (BCR) induced
activation [7,8], in NK cell-mediated cytotoxicity [9] and in
basophilic cell degranulation [10,11] have also been described.
3BP2 associates several signaling partners including Src/Syk
kinases, LAT, Vav proteins, PLC-c and 14-3-3 chaperon pro-
teins (reviewed in [12]). Finally, mutations in the 3bp2/sh3bp2
gene were identiﬁed to cause a human bone disease called cher-
ubism [13]. Altogether these observations suggest that 3BP2
may play a crucial role in PTK-dependent signaling pathways
during hematopoietic cells diﬀerentiation and function. How-
ever, the mechanisms by which 3BP2 regulates cell activation
are poorly understood.
To gain insights in 3BP2 function, we searched for novel
3BP2 interacting proteins. We describe here that 3BP2 inter-
acts with the CMS family member CIN85/CD2AP/SH3KBP1
and the actin-binding protein HIP-55/SH3P7/mAbp1, two
adapter proteins involved in intracellular traﬃcking and actin
regulation.2. Materials and methods
2.1. Reagents, antibodies and plasmids
Culture media, oligonucleotides, and enzymes were from Invitrogen
(The Netherlands). Chemicals were from Sigma (St. Louis, MO). The
generation of rabbit polyclonal antibodies against hematopoietic pro-
genitor kinase 1 interacting protein of 55 kDa (HIP-55) was described
before [14]. Antibodies against Cbl interacting protein of 85 kDa
(CIN85) were previously described [15]. Antibodies speciﬁc for Cbl
and GST were from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Anti-myc (9E10) and anti-hemagglutinin (HA; 12CA5) mAbs
were from Upstate Biotechnology Inc. (Lake Placid, USA) and Roche
Diagnostics (Switzerland), respectively. The anti-V5 mAb and anti-
Flag mAb were from Invitrogen. Staphylococcal enterotoxins A, B
and E were from Toxin Technologies (Madison, WI).
The yeast expression plasmids and the HA-tagged 3BP2 constructs
were described [4,16]. Point and deletion mutants were generated by
PCR using QuickChange mutagenesis kit (Stratagene). Mutations were
veriﬁed by DNA sequencing. A GFP-tagged 3BP2 expression vector
was obtained by sub-cloning the HA-tagged 3BP2 cDNA from
pMT3 vector into pEGFP-C3 plasmid (Clontech, CA). In-frame inser-
tion of the murine 3BP2 cDNA into the pCS3 6-myc vector was per-
formed by polymerase chain reaction (PCR) using High Fidelity
Platinium Taq DNA polymerase (Invitrogen). Plasmids encoding
Flag-tagged CIN85, GST–CIN85 SH3 domains were kindly provided
by Dr Dikic [15]. Bacterial expression plasmids of GST–HIP-55 fusion
proteins and V5-tagged HIP-55 expression vectors have been described
previously [17].blished by Elsevier B.V. All rights reserved.
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Yeast two-hybrid protocols and cDNA library screening were per-
formed as previously described [4,7]. The leukemic Jurkat T and
Raji B lymphoma cells were grown in RPMI 1640 medium, supple-
mented with 10% fetal calf serum (FCS; Dutcher, France), 2 mM
glutamine, 1 mM sodium pyruvate, 10 mM HEPES, non-essential
amino acids solution, and 100 U/ml of penicillin and streptomycin.
Cells were transfected with the indicated amounts of plasmids by
electroporation using the Gene Pulser apparatus (Bio-Rad Laborato-
ries) [7]. Transient transfections into human T lymphocytes were
performed using the AMAXA nucleofection system (AMAXA
GmbH, Germany) according to the manufacturer’s instructions.
Brieﬂy, puriﬁed CD4+ T cells (107) were washed and resuspended
in 100 ll of nucleofection solution (AMAXA), mixed with 5 lg of
plasmid DNA and electroporated using program U-15 on AMAXA
nucleofector device. Cells were rapidly transferred to 37 C pre-
heated culture medium and incubated for 24–48 h at 37 C, 5%
CO2. COS cells were cultured in Dulbecco modiﬁed Eagle’s medium
(Invitrogen) with 10% FCS. 1 · 107 cells were plated the day before
transfection. Transfections were then performed by calcium phos-
phate precipitation method.
2.3. Cell conjugation and immunoﬂuorescence microscopy
Conjugates formation was performed as described [17]. Brieﬂy, Raji
B cells were pulsed or not with 5 lg/ml of mixed SEA, SEB and SEE
for 1 h at 37 C. Raji cells and transfected primary T cells were then
mixed at a 1:1.5 ratio and incubated at 37 C for 30 min. The conju-
gates were then gently resuspended and plated onto poly-L-lysine-
coated slides for 20 min before ﬁxation. Cells were ﬁxed in 3.7% (w/
v) paraformaldehyde, permeabilized in 0.2% Triton X-100, blocked
in PBS–saponin–BSA and stained with indicated primary and second-
ary antibodies. After labeling, samples were mounted in Mowiol (Cal-
biochem) and analyzed by confocal microscopy (Leica TCS-SP,
Germany).clone
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negative control and 3BP2-Vav1 interaction is shown here as a positive contr
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no interaction; (+++) strong interaction. Similar results were obtained by as2.4. GST pulldown assays, immunoprecipitation, immunoblotting and
ligand blotting
Glutathione S-transferase (GST) pulldown assays, immunoprecipi-
tation, immunoblotting procedures were performed as previously
described [7,16]. For ligand blotting using recombinant proteins,
electrophorezed immunoprecipitates were transferred to membranes
and incubated with GST–HIP-55-SH3 or GST–CIN85-SH3A (10 lg/
ml) for 16 h at 4 C. After extensive washings, the membranes were
successively incubated with anti-GST and HRP-conjugated antibodies
followed by enhanced chemiluminescence detection.
2.5. Isolation of GEM fractions
Jurkat cells (1 · 108) were either left unstimulated or stimulated with
anti-CD3 mAb (5 lg/ml) for the indicated times. After washing in ice-
cold PBS, cells were lysed in ice-cold buﬀer containing 25 mM Tris–
HCl pH 7.5, 150 mM NaCl, 5 mM EGTA, 0.2 mM Na2VO4) contain-
ing 0.5% Triton X-100 and protease inhibitors. The ratio of lysis buﬀer
volume to cell number was kept constant throughout the experiments.
After 30 min on ice, the preparation was made 40% with respect to su-
crose, and 0.8 ml of lysate–sucrose mixture was overlaid with 2 ml of
30% sucrose and 1 ml of 4% sucrose prepared in the above buﬀer.
The mixture was centrifuged at 200000 · g for 14–16 h in an SW50.1
rotor (Beckman). The gradient was fractionated into 0.5 ml fractions
from the top of the tube that were analyzed by immunoblotting.3. Results
3.1. Identiﬁcation of HIP-55 and CIN85 as 3BP2 interacting
proteins in yeast
In order to identify novel 3BP2 interacting proteins, a yeast
two-hybrid screen of a human lymphocyte cDNA library using3
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of the clones isolated during this screen aligned to the sche-
matic protein structure of HIP-55 (BIP1) and CIN85 (BIP2).
A b-galactosidase activity ﬁlter assay showed that these inter-
actions were speciﬁc. Whereas the interaction between 3BP2
and CIN85 was comparable with the interaction between
3BP2 and Vav1 [7], we found that the interaction between
HIP-55 and 3BP2 was weaker (Fig. 1A). Further analysis per-
formed in yeast using various deletion mutants of 3BP2 indi-
cated that HIP-55 (BIP1) interacted with the proline-rich
domain (PR3) located between aa 349 and 384, whereas
CIN85 binding domain on 3BP2 mapped to the PR1 domain
located between aa 201 and 240, overlapping with the Vav1
binding sequence. Apparently, another proline-rich sequence
(PR2) is dispensable in those interactions (Fig. 1B).
3.2. 3BP2 interacts with the SH3 domains of CIN85 and HIP-55
To conﬁrm the above interactions in mammalian cells, we
performed pull-down assays with GST fusion proteins contain-
ing diﬀerent regions of CIN85 or HIP-55 incubated with ly-
sates from COS cells transfected with 3BP2. All single SH3
domains of CIN85 as well as the three combined SH3 domainsGST-CIN85
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action was detected with GST alone (Fig. 2A). GST fusion
proteins containing the SH3 domain of HIP-55 interacted with
3BP2 whereas no interaction was detected with GST alone or
with GST fused to ADF-H or helical domains of HIP-55
(Fig. 3A). To further characterize interactions between 3BP2
and the SH3 domains of CIN85 and HIP-55, we performed
co-immunoprecipitations analysis on lysates from COS cells
transfected with 3BP2 and various CIN85 and HIP-55 con-
structs. 3BP2 co-immunoprecipitated with wild-type CIN85
proteins, but not with CIN85 proteins containing the pro-
line-rich coiled-coil moiety of CIN85 (Fig. 2B). Similarly,
3BP2 co-immunoprecipitated with wild-type and DADF
HIP-55 proteins whereas no interaction was detected between
3BP2 and DSH3 HIP-55 proteins (Fig. 3B). Finally, we used a
ligand blot approach to show that interactions between 3BP2
and either the SH3A domain of CIN85 (Fig. 2C) or the SH3
domain of HIP-55 (Fig. 3C) are direct. HA-tagged 3BP2 pro-
teins were immunoprecipitated from cell lysates, resolved on
SDS–PAGE and transferred to nitrocellulose membranes that
were incubated with GST fusion proteins. The binding of
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Fig. 3. 3BP2 interaction with the SH3 domain of HIP-55. (A) GST fusion proteins (5 lg) containing the indicated region of HIP-55 or GST alone
immobilized on glutathione Sepharose beads were incubated with equal amounts of lysates from COS cells transiently transfected with 3BP2-myc.
After washing, proteins were separated by SDS–PAGE and associated 3BP2 were visualized by immunoblotting with anti-myc antibody (upper
panel), while the levels of used GST constructs were visualized by anti-GST immunoblotting (lower panel). (B) COS cells were transiently transfected
with 3BP2-myc in combination with empty vector, wild-type HIP-55-V5, DADF-H HIP-55-V5 or DSH3 HIP-55-V5. Lysates were immunopre-
cipitated with anti-V5 antibody and separated by SDS–PAGE. The immunoprecipitates and whole-cell lysates were blotted with anti-myc or anti-V5
antibodies. (C) Equal amounts of lysates from COS cells transiently transfected with HA-3BP2 were immunoprecipitated with anti-HA antibody and
protein G-Sepharose. Immunoprecipitates were resolved by SDS–PAGE and transferred onto nitrocellulose membrane. Membranes were incubated
with GST–HIP-55 SH3 domain fusion proteins and binding was detected with anti-GST immunoblotting. The membrane was then stripped and
reprobed with anti-HA antibody.
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Together, these data indicate that interactions between 3BP2
and either CIN85 or HIP-55 are direct and mediated by their
SH3 domains.
3.3. CIN85 and HIP-55 SH3 domains interact with diﬀerent
proline-rich sequences in 3BP2
Analysis performed in yeast showed that the proline-rich do-
main of 3BP2 located between aa 201 and 240 (PR1) mediated
the interaction with CIN85. This domain contains the
PVPVPR213 motif matching the PxPxPR consensus sequence
for binding to SH3 domains of CIN85, and arginine mutation
within this sequence was shown to disrupt ligand binding [18].
In order to determine whether the PVPTPR sequence mediates
the interaction with CIN85, we mutated the arginine 213 of
this motif to alanine. As a control, we also mutated to alanine
the arginine 402 of another carboxy-terminal PxxxPR motif
found in 3BP2. We then performed pull-down assays with
GST fused to CIN85 SH3ABC domains or to HIP-55 SH3 do-
main incubated with lysates from cells transfected with wild-
type 3BP2, R213A or R402A mutants (Fig. 4). The association
between 3BP2 and CIN85 SH3 domains was impaired when
arginine 213 was changed to alanine, whereas R402A mutation
had no signiﬁcant eﬀect as compared to wild-type 3BP2(Fig. 4). As a control, the interaction between CIN85 SH3ABC
domains and c-Cbl was not altered by 3BP2 proteins co-
expression. On the other hand, the association between 3BP2
and HIP-55 SH3 domain was disrupted when R402A 3BP2
mutant was transfected instead of wild-type or R213A pro-
teins. Interestingly, we also observed an interaction between
c-Cbl and the SH3 domain of HIP-55, which was signiﬁcantly
decreased following wild-type and R213A 3BP2 proteins co-
expression, but not following R402A mutant co-expression
(Fig. 4). Together, these data identiﬁed proline-rich sequences
in 3BP2 that diﬀerentially associate HIP-55 and CIN85 SH3
domains.
3.4. Co-localization of 3BP2, CIN85 and HIP-55 in lymphocyte
3BP2 has been implicated in lymphocyte signaling down-
stream immunoreceptors [4,7,8]. We therefore investigated
the potential association of 3BP2, HIP-55 and CIN85 in gly-
cosphigolipid-enriched membrane microdomains (GEMs)
and in the immunological synapse, two supramolecular struc-
tures with pivotal roles in lymphocyte activation. GEMs from
unstimulated and TCR-stimulated Jurkat T cells were deter-
gent solubilized and separated following density gradient ultra-
centrifugation. The distribution of 3BP2, HIP-55 and CIN85
proteins in the diﬀerent fractions was analyzed by immuno-
blotting. A minor but signiﬁcant fraction of 3BP2, HIP-55
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Fig. 4. HIP-55 and CIN85 interact with diﬀerent domains of 3BP2. (A) GST fusion proteins (5 lg) containing CIN85 SH3A domain, HIP-55 SH3
domain or GST alone immobilized on glutathione Sepharose beads were incubated with equal amounts of lysates from Jurkat cells transfected with
empty vector (pMT3), wild-type HA-3BP2, HA-3BP2 R213A or HA-3BP2 R402A. After washing, proteins were separated by SDS–PAGE and
associated 3BP2 were visualized by immunoblotting with anti-HA antibody (upper panel). The membrane was stripped and reprobed with anti-c-Cbl
antibody (lower panel). (B) Anti-HA and anti-c-Cbl immunoblotting of whole cell lysates showing equal protein loading.
Fig. 5. Localization of 3BP2, HIP-55 and CIN85 in GEMs upon TCR
stimulation. Jurkat T cells were either left unstimulated or stimulated
with an anti-CD3 antibody for 5 min. Cells were detergent solubilized
and cell fractions were separated following density gradient ultracen-
trifugation as described in Section 2. The fractions were numbered
from top to bottom of the gradient. Distribution of 3BP2, HIP-55 and
CIN85 proteins was analyzed by SDS–PAGE and immunoblotting as
indicated. Distribution of LAT and Vav1 was analyzed as controls for
GEMs isolation and 3BP2 interaction.
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stimulated Jurkat T cells (Fig. 5). Interestingly, a small fraction
of another 3BP2 partner, Vav1, was also detected in GEMs
from activated T cells, whereas the transmembrane adapter
LAT was predominantly present in GEMs from unstimulated
and activated T cells. Previous studies have implicated HIP-55
[14,19] and CIN85 [20] in regulation of endocytosis. Since theimmunological synapse formed between T cell and APCs has
been identiﬁed as an active zone of receptors and proteins recy-
cling [21], we therefore examined the physical association be-
tween 3BP2, CIN85 and HIP-55 in human peripheral T cells
transfected with GFP-3BP2 and Flag-CIN85 (Fig. 6A) or with
GFP-3BP2 and HIP-55-V5 (Fig. 6B), and conjugated with un-
pulsed or superantigen-pulsed Raji B cells. Microscopy analy-
sis of the cell–cell conjugates showed that 3BP2 co-localized
with CIN85 or with HIP-55 at the T cell–APC interface. Inter-
estingly, in T cells conjugated with unpulsed B cells, these pro-
teins were also found co-localized, although in T cell
cytoplasmic regions outside the synapse. Together, these data
indicate that 3BP2, CIN85 and HIP-55 co-localized in unstim-
ulated and activated lymphocytes.4. Discussion
3BP2 (also known as Abl SH3 binding protein 2 or SH3BP2)
is a cytoplasmic adapter involved in leukocyte signaling down-
stream Src/Syk-kinases coupled immunoreceptors [8,12]. How-
ever, its exact function and the mechanisms by which 3BP2
regulates leukocyte activation remain unclear. Here, we de-
scribe the identiﬁcation of two novel partners of 3BP2, the
adapter proteins CIN85/CD2AP/SH3KBP1 and HIP-55/
SH3P7/mAbp1 involved in endocytosis and actin regulation.
Yeast two-hybrid interaction analysis and biochemical assays
revealed that 3BP2 directly interacted with the SH3 domains
of either CIN85 or HIP-55, through diﬀerent proline-rich se-
quences.
CIN85 belongs to the CMS family of ubiquitously
expressed adaptors containing three N-terminal SH3 domains,
Fig. 6. 3BP2 interacts with CIN85 and HIP-55 in resting and antigen-stimulated T lymphocytes. Human peripheral T cells were transiently
electroporated using the AMAXA nucleofection system with a combination of either GFP-3BP2 and Flag-CIN85 (A) or GFP-3BP2 and HIP-55-V5
(B). Transfected T lymphocytes were then mixed at a 1:1.5 ratio with Raji B cells that were left untreated (Sags) or pulsed with 5 lg/ml of mixed
SEA, SEB and SEE superantigens (+Sags). Following 30 min of incubation at 37 C in 5% CO2 atmosphere, the conjugates resuspended onto poly-L-
lysine-coated slides were analyzed by confocal microscopy. White stars indicate the transfected T lymphocyte.
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shown to associate with several molecules, including endocytic
proteins like endophilins, components of the actin cytoskele-
ton and other adaptors involved in receptor tyrosine kinases
signaling. The multimeric complexes assembled by CIN85
have been involved in receptor internalization and down-regu-
lation of PTKs signaling in diﬀerent cell types [15,22]. Another
adaptor protein known as CD2AP (or Cas ligand with multi-
ple SH3 domains, CMS) highly similar to CIN85 was impli-
cated in T cell signaling down-regulation [21] and epithelial
cell function in kidney [23]. A recent study has determined that
optimal binding sites for the SH3 domains of CIN85 are com-
posed of atypical polyproline–arginine motifs PxxxPR present
in CIN85 ligands such as CD2 receptor, the E3 ubiquitin li-
gases c-Cbl and Cbl-b, and adapters SLP-76 and BLNK [18].
The central proline-rich region of 3BP2 contains several
PxxxPR motifs. However, deletion analysis of 3BP2 in yeast
and mammalian cells combined to ligand blot analysis mapped
the binding site of CIN85 SH3 domains on 3BP2 to the ﬁrst
proline-rich region PR1 which contains the PVPTPR213 motif.
Importantly, the mutation of the arginine residue of this motif
impaired 3BP2 binding to CIN85, suggesting that it represents
the major CIN85 binding site on 3BP2. Consistently, this motif
matched the consensus motif PxPxPR previously identiﬁed as
a speciﬁc binding motif for CIN85 SH3 domains [18].
Our study also identiﬁed the actin-binding protein and Src/
Syk-kinases substrate HIP-55 as a direct binding partner of
3BP2. HIP-55 (hematopoeitic protein kinase 1 interacting
protein of 55 kDa) [17,24] is composed of an N-terminal ac-
tin-depolymerizing factor homology (ADF-H) domain, two
consensus tyrosine phosphorylation sites and a C-terminal
SH3 domain. HIP-55, a member of the drebrin/Abp1 family
of F-actin binding proteins [25,26], is involved in signalingevents connected to endocytic traﬃcking and cytoskeletal reg-
ulation [19,27]. HIP-55/SH3P7 was found to be a substrate of
Src/Syk-kinases in T [28,29] and B [30] cells, suggesting that it
represents a common eﬀector of antigen receptors signaling
pathways in leukocytes. Indeed, an important function during
T cell proliferation and immune responses was recently attrib-
uted to HIP-55 [29]. In non-lymphoid cells, HIP-55 is required
for endocytosis [14,31] and associates with dynamin, a GTPase
that functions in endocytosis [19]. We recently found that HIP-
55 was redistributed to the T cell-antigen-presenting cells
(APCs) synapse in antigen-dependent manner and localized
with endosomes where it may regulate T cell receptor (TCR)
down-modulation [17]. Together, these data indicate that
HIP-55 may connect actin cytoskeleton to endocytic functions.
Here, the SH3 domain of HIP-55 was shown to bind a distal
polyproline region of 3BP2 located between amino acids 349
and 402, overlapping several polyproline motifs ﬂanked by po-
sitive charges which share some similarities with the preferred
binding sequence previously reported for Abp1 SH3 domain
[32]. Of note, whereas the interaction between 3BP2 and
CIN85 was comparable with the interaction between 3BP2
and Vav1, the interaction between HIP-55 and 3BP2 was
weaker, indicating diﬀerences in speciﬁcity of interaction.
Although the deﬁnitive binding sites of HIP-55 and CIN85
SH3 domains for the diﬀerent regions of 3BP2 are currently
unknown, our observations suggest that CIN85 and HIP-55
SH3 domains may have overlapping binding speciﬁcity. Sur-
prisingly, the SH3 domain of HIP-55 associated c-Cbl, another
CIN85 binding molecule [18]. How speciﬁc is this interaction is
currently unknown. However, other domains of HIP-55 did
not interact with c-Cbl (data not shown). In addition, the
SH3 domains of CIN85 interacted simultaneously with c-Cbl
and 3BP2, suggesting the possible existence of a multimolecu-
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Clearly, further investigations are required in order to identify
the deﬁnitive binding domains of these proteins to 3BP2 and
their respective speciﬁcity.
The question raised by our study points to the functional
importance of these interactions. 3BP2 co-localized with
CIN85 and HIP-55 within T cell rafts (or GEMs) and the T
cell/APC synapse, two supramolecular structures with pivotal
roles in lymphocyte activation. In our experiments, only a
small fraction of these proteins appears to relocalize into
GEMs. However, these observations are consistent with previ-
ous reports [28,33]. The immunological synapse represents an
active zone of receptors and proteins recycling and actin reor-
ganization [34]. The Cbl family of ubiquitin ligases regulates
ubiquitin-mediated protein traﬃcking and degradation in sev-
eral cell types [35,36], and c-Cbl and Cbl-b activities were
showed to critically aﬀect TCR expression and T cell respon-
siveness to antigen stimulation [37]. Moreover, CIN85 consti-
tutively interacts with endophilins, critical regulators of
chlathrin-mediated endocytosis of activated receptor tyrosine
kinases [15,22]. CD2AP, which is highly similar to CIN85,
was involved in T cell signaling regulation [21]. In a previous
study, we found that HIP-55 participated to lymphoid and
non-lymphoid endocytic pathways [14,17]. More recently,
HIP-55 was implicated in clathrin-mediated endocytosis [31].
Conversely, CIN85 and CMS/CD2AP have also been involved
in actin regulation [38,39]. Both HIP-55 and CMS/CIN85 were
found within the immunological synapse, where they likely co-
localize with polymerized actin and activated TCRs [17,38]. As
we found here a similar distribution for 3BP2, it is therefore
tempting to speculate that 3BP2 might regulate TCR-mediated
endocytic pathways through its association with CIN85 and
HIP-55. Interestingly, another 3BP2 binding protein, the
Rho GTPases activator Vav [7], has been involved in immuno-
logical synapse formation [40] and FcR-mediated phagocytosis
[41]. Thus, 3BP2 may participate to the assembly of multimo-
lecular complexes containing Cbl, Vav, CIN85 and HIP-55
and regulating actin cytoskeleton-dependent endocytic traf-
ﬁcking in leukocytes. Owing the recent implication of 3BP2
in BCR signaling [7,8] and myeloid cell responses [42], it is
likely that these molecular complexes could also play an
important role during B and myeloid cell activation. In conclu-
sion, our study reveals an unexpected role of 3BP2 in lympho-
cyte signaling by linking Src/Syk-kinases to endocytic and
cytoskeletal regulation through its interaction with CIN85
and HIP-55 (Fig. 7). This function of 3BP2 appears signiﬁ-
cantly diﬀerent to previous ones in which 3BP2 was assignedto as a positive regulator of leukocyte signaling downstream
immunoreceptors. Future works may elucidate the physiolog-
ical relevance to leukocyte biology of these multiple interac-
tions and functions involving 3BP2.
Acknowledgements: This work was supported by INSERM and by
grants from the Association pour la Recherche sur le Cancer (ARC
3111) and the Ministe`re de l’Enseignement et de la Recherche.
S.L.B. was supported by a doctoral fellowship from ARC. We thank
Dr. Ivan Dikic for kindly providing CIN85 reagents and plasmids,
Dr. Yun-Cai Liu for c-Cbl vector, Dr. Serge Manie´ for his help with
rafts puriﬁcation, and Drs. Rob Rottapel and Sophie Tartare-Deckert
for helpful discussions.References
[1] Samelson, L.E. (2002) Signal transduction mediated by the T cell
antigen receptor: the role of adapter proteins. Annu. Rev.
Immunol. 20, 371–394.
[2] Kurosaki, T. (2000) Functional dissection of BCR signaling
pathways. Curr. Opin. Immunol. 12, 276–281.
[3] Tomlinson, M.G., Lin, J. and Weiss, A. (2000) Lymphocytes with
a complex: adapter proteins in antigen receptor signaling.
Immunol. Today 21, 584–591.
[4] Deckert, M., Tartare-Deckert, S., Hernandez, J., Rottapel, R. and
Altman, A. (1998) Adaptor function for the Syk kinases-
interacting protein 3BP2 in IL-2 gene activation. Immunity 9,
595–605.
[5] Ren, R., Mayer, B.J., Cicchetti, P. and Baltimore, D. (1993)
Identiﬁcation of a ten-amino acid proline-rich SH3 binding site.
Science 259, 1157–1161.
[6] Bell, S.M., Shaw, M., Jou, Y.S., Myers, R.M. and Knowles, M.A.
(1997) Identiﬁcation and characterization of the human homo-
logue of SH3BP2, an SH3 binding domain protein within a
common region of deletion at 4p16.3 involved in bladder cancer.
Genomics 44, 163–170.
[7] Foucault, I., Le Bras, S., Charvet, C., Moon, C., Altman, A. and
Deckert, M. (2005) The adaptor protein 3BP2 associates with
VAV guanine nucleotide exchange factors to regulate NFAT
activation by the B-cell antigen receptor. Blood 105, 1106–1113.
[8] de la Fuente, M.A., Kumar, L., Lu, B. and Geha, R.S. (2006)
3BP2 deﬁciency impairs the response of B cells, but not T cells, to
antigen receptor ligation. Mol. Cell. Biol. 26, 5214–5225.
[9] Jevremovic, D., Billadeau, D.D., Schoon, R.A., Dick, C.J. and
Leibson, P.J. (2001) Regulation of NK cell-mediated cytotoxicity
by the adaptor protein 3BP2. J. Immunol. 166, 7219–7228.
[10] Sada, K., Miah, S.M., Maeno, K., Kyo, S., Qu, X. and
Yamamura, H. (2002) Regulation of FcepsilonRI-mediated
degranulation by an adaptor protein 3BP2 in rat basophilic
leukemia RBL-2H3 cells. Blood 100, 2138–2144.
[11] Maeno, K., Sada, K., Kyo, S., Miah, S.M., Kawauchi-Kamata,
K., Qu, X., Shi, Y. and Yamamura, H. (2003) Adaptor protein
3BP2 is a potential ligand of Src homology 2 and 3 domains of
Lyn protein-tyrosine kinase. J. Biol. Chem. 278, 24912–24920.
974 S. Le Bras et al. / FEBS Letters 581 (2007) 967–974[12] Deckert, M. and Rottapel, R. (2006) The adapter 3BP2: how it
plugs into leukocyte signaling (Tsoukas, C., Ed.), Advances in
Experimental Medical and Biology, Vol. 584, pp. 107–114,
Springer, New York, NY.
[13] Ueki, Y., Tiziani, V., Santanna, C., Fukai, N., Maulik, C.,
Garﬁnkle, J., Ninomiya, C., doAmaral, C., Peters, H., Habal, M.,
Rhee-Morris, L., Doss, J.B., Kreiborg, S., Olsen, B.R. and
Reichenberger, E. (2001) Mutations in the gene encoding c-Abl-
binding protein SH3BP2 cause cherubism. Nat. Genet. 28, 125–
126.
[14] Mise-Omata, S., Montagne, B., Deckert, M., Wienands, J. and
Acuto, O. (2003) Mammalian actin binding protein 1 is essential
for endocytosis but not lamellipodia formation: functional
analysis by RNA interference. Biochem. Biophys. Res. Commun.
301, 704–710.
[15] Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W.Y.
and Dikic, I. (2002) Cbl–CIN85–endophilin complex mediates
ligand-induced downregulation of EGF receptors. Nature 416,
183–187.
[16] Foucault, I., Liu, Y.C., Bernard, A. and Deckert, M. (2003) The
chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and
regulates its adapter function. J. Biol. Chem. 278, 7146–7153.
[17] Le Bras, S., Foucault, I., Foussat, A., Brignone, C., Acuto, O. and
Deckert, M. (2004) Recruitment of the actin-binding protein HIP-
55 to the immunological synapse regulates T cell receptor
signaling and endocytosis. J. Biol. Chem. 279, 15550–15560.
[18] Kowanetz, K., Szymkiewicz, I., Haglund, K., Kowanetz, M.,
Husnjak, K., Taylor, J.D., Soubeyran, P., Engstrom, U., Lad-
bury, J.E. and Dikic, I. (2003) Identiﬁcation of a novel proline–
arginine motif involved in CIN85-dependent clustering of Cbl and
down-regulation of epidermal growth factor receptors. J. Biol.
Chem. 278, 39735–39746.
[19] Kessels, M.M., Engqvist-Goldstein, A.E., Drubin, D.G. and
Qualmann, B. (2001) Mammalian Abp1, a signal-responsive F-
actin-binding protein, links the actin cytoskeleton to endocytosis
via the GTPase dynamin. J. Cell Biol. 153, 351–366.
[20] Dikic, I. (2002) CIN85/CMS family of adaptor molecules. FEBS
Lett. 529, 110–115.
[21] Lee, K.H., Dinner, A.R., Tu, C., Campi, G., Raychaudhuri, S.,
Varma, R., Sims, T.N., Burack, W.R., Wu, H., Wang, J.,
Kanagawa, O., Markiewicz, M., Allen, P.M., Dustin, M.L.,
Chakraborty, A.K. and Shaw, A.S. (2003) The immunological
synapse balances T cell receptor signaling and degradation.
Science 302, 1218–1222.
[22] Petrelli, A., Gilestro, G.F., Lanzardo, S., Comoglio, P.M.,
Migone, N. and Giordano, S. (2002) The endophilin–CIN85–
Cbl complex mediates ligand-dependent downregulation of c-
Met. Nature 416, 187–190.
[23] Shih, N.Y., Li, J., Karpitskii, V., Nguyen, A., Dustin, M.L.,
Kanagawa, O., Miner, J.H. and Shaw, A.S. (1999) Congenital
nephrotic syndrome in mice lacking CD2-associated protein.
Science 286, 312–315.
[24] Ensenat, D., Yao, Z., Wang, X.S., Kori, R., Zhou, G., Lee, S.C.
and Tan, T.H. (1999) A novel src homology 3 domain-containing
adaptor protein, HIP-55, that interacts with hematopoietic
progenitor kinase 1. J. Biol. Chem. 274, 33945–33950.
[25] Drubin, D.G., Mulholland, J., Zhu, Z.M. and Botstein, D. (1990)
Homology of a yeast actin-binding protein to signal transduction
proteins and myosin-I. Nature 343, 288–290.
[26] Lappalainen, P., Kessels, M.M., Cope, M.J. and Drubin, D.G.
(1998) The ADF homology (ADF-H) domain: a highly exploited
actin-binding module. Mol. Biol. Cell. 9, 1951–1959.[27] Olazabal, I.M. and Machesky, L.M. (2001) Abp1p and cortactin,
new ‘‘hand-holds’’ for actin. J. Cell Biol. 154, 679–682.
[28] Han, J., Kori, R., Shui, J.W., Chen, Y.R., Yao, Z. and Tan, T.H.
(2003) The SH3 domain-containing adaptor HIP-55 mediates
c-Jun N-terminal kinase activation in T cell receptor signaling.
J. Biol. Chem. 278, 52195–52202.
[29] Han, J., Shui, J.W., Zhang, X., Zheng, B., Han, S. and Tan, T.H.
(2005) HIP-55 is important for T-cell proliferation, cytokine
production, and immune responses. Mol. Cell Biol. 25, 6869–
6878.
[30] Larbolette, O., Wollscheid, B., Schweikert, J., Nielsen, P.J. and
Wienands, J. (1999) SH3P7 is a cytoskeleton adapter protein and
is coupled to signal transduction from lymphocyte antigen
receptors. Mol. Cell Biol. 19, 1539–1546.
[31] Connert, S., Wienand, S., Thiel, C., Krikunova, M., Glyvuk, N.,
Tsytsyura, Y., Hilﬁker-Kleiner, D., Bartsch, J.W., Klingauf, J.
and Wienands, J. (2006) SH3P7/mAbp1 deﬁciency leads to tissue
and behavioral abnormalities and impaired vesicle transport.
Embo J. 25, 1611–1622.
[32] Fazi, B., Cope, M.J., Douangamath, A., Ferracuti, S., Schirwitz,
K., Zucconi, A., Drubin, D.G., Wilmanns, M., Cesareni, G. and
Castagnoli, L. (2002) Unusual binding properties of the SH3
domain of the yeast actin-binding protein Abp1: structural and
functional analysis. J. Biol. Chem. 277, 5290–5298.
[33] Qu, X., Kawauchi-Kamata, K., Miah, S.M., Hatani, T., Yamam-
ura, H. and Sada, K. (2005) Tyrosine phosphorylation of adaptor
protein 3BP2 induces T cell receptor-mediated activation of
transcription factor. Biochemistry 44, 3891–3898.
[34] Shaw, A.S. (2005) T-cell activation and immunological synapse.
Immunol. Res. 32, 247–252.
[35] Sanjay, A., Horne, W.C. and Baron, R. (2001) The Cbl family:
ubiquitin ligases regulating signaling by tyrosine kinases. Sci.
STKE 2001, PE40.
[36] Rao, N., Dodge, I. and Band, H. (2002) The Cbl family of
ubiquitin ligases: critical negative regulators of tyrosine kinase
signaling in the immune system. J. Leukoc. Biol. 71, 753–763.
[37] Liu, Y.C. and Gu, H. (2002) Cbl and Cbl-b in T-cell regulation.
Trends Immunol. 23, 140–143.
[38] Hutchings, N.J., Clarkson, N., Chalkley, R., Barclay, A.N. and
Brown, M.H. (2003) Linking the T cell surface protein CD2 to the
actin-capping protein CAPZ via CMS and CIN85. J. Biol. Chem.
278, 22396–22403.
[39] Bruck, S., Hubert, T., Ingham, R., Kim, K., Niederstrasser, H.,
Allen, P., Pawson, T., Cooper, J.A. and Shaw, A.S. (2006)
Identiﬁcation of a novel inhibitory actin-capping protein binding
motif in CD2-associated protein. J. Biol. Chem. 281, 19196–
19203.
[40] Ardouin, L., Bracke, M., Mathiot, A., Pagakis, S.N., Norton, T.,
Hogg, N. and Tybulewicz, V.L. (2003) Vav1 transduces TCR
signals required for LFA-1 function and cell polarization at the
immunological synapse. Eur. J. Immunol. 33, 790–797.
[41] Patel, J.C., Hall, A. and Caron, E. (2002) Vav regulates activation
of Rac but not Cdc42 during FcgammaR-mediated phagocytosis.
Mol. Biol. Cell. 13, 1215–1226.
[42] Ueki, Y., Lin, C.Y., Senoo, M., Ebihara, T., Agata, N., Onji, M.,
Saheki, Y., Kawai, T., Mukherjee, P.M., Reichenberger, E. and
Olsen, B.R. (2007) Increased myeloid cell responses to M-CSF
and RANKL cause bone loss and inﬂammation in SH3BP2
‘‘Cherubism’’ mice. Cell 128, 71–83.
